好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

PRISM II: Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA®) for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Combined Results of a Multicenter Open-Label Study
Aging, Dementia, and Behavioral Neurology
(-)
225
Authors/Disclosures
Joao O. Siffert, MD
PRESENTER
No disclosure on file
Flora M. Hammond, MD Dr. Hammond has received publishing royalties from a publication relating to health care.
David N. Alexander, MD (University of California) Dr. Alexander has received personal compensation in the range of $10,000-$49,999 for serving as a Medical expert with HHS Dept of Vaccine Injury.
No disclosure on file
No disclosure on file
Rachelle S. Doody, MD, PhD Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.
No disclosure on file
Richard Zorowitz Richard Zorowitz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SPR Therapeutics. The institution of Richard Zorowitz has received research support from Ipsen Pharmaceuticals. Richard Zorowitz has received publishing royalties from a publication relating to health care.
No disclosure on file
Paul Shin (Avanir Pharmaceuticals) No disclosure on file
No disclosure on file
Charles Yonan, PharmD (Avanir Pharmaceuticals) No disclosure on file
Andrea Formella, PharmD, BCPP (Supernus Pharmaceuticals) Dr. Formella has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc. Dr. Formella has stock in Supernus Pharmaceuticals, Inc..